カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のヒトヘルパーウイルス5（HHV-5）治療薬市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Human Herpersvirus 5 (HHV-5) Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19393）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19393
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：107
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のヒトヘルパーウイルス5（HHV-5）治療薬市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ヒトヘルパーウイルス5（HHV-5）治療薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のヒトヘルパーウイルス5（HHV-5）治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ヒトヘルパーウイルス5（HHV-5）治療薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ガンシクロビル、バレリアンギリビル製剤、アシクロビル製剤、バラシクロビル製剤、ホスカルネットナトリウム製剤

用途別セグメントは次のように区分されます。
・免疫不全群集、臓器移植群群、CMVヘルペス群集

世界のヒトヘルパーウイルス5（HHV-5）治療薬市場の主要な市場プレーヤーは以下のとおりです。
・Roche、Livzon Pharmaceuticals、Sichuan Cologne Pharmaceutical、Hubei Branch benefits medicine、GlaxoSmithKline、Upright and clear、Chongqing Winbond (acquisition of Sichuan Mingxin)、Haikou Kellett、On the drug new Asia、Chongqing Fu'an Pharmaceutical、Shandong Luo Xin Pharmaceutical、Yangtze River Pharmaceutical、Qianjiang Pharmaceuticals、Wuhan Hualong

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ヒトヘルパーウイルス5（HHV-5）治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なヒトヘルパーウイルス5（HHV-5）治療薬メーカーの企業概要、2019年～2022年までのヒトヘルパーウイルス5（HHV-5）治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なヒトヘルパーウイルス5（HHV-5）治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ヒトヘルパーウイルス5（HHV-5）治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのヒトヘルパーウイルス5（HHV-5）治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのヒトヘルパーウイルス5（HHV-5）治療薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびヒトヘルパーウイルス5（HHV-5）治療薬の産業チェーンを掲載しています。
・第13、14、15章では、ヒトヘルパーウイルス5（HHV-5）治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ヒトヘルパーウイルス5（HHV-5）治療薬の概要
- 種類別分析（2017年vs2021年vs2028年）：ガンシクロビル、バレリアンギリビル製剤、アシクロビル製剤、バラシクロビル製剤、ホスカルネットナトリウム製剤
- 用途別分析（2017年vs2021年vs2028年）：免疫不全群集、臓器移植群群、CMVヘルペス群集
- 世界のヒトヘルパーウイルス5（HHV-5）治療薬市場規模・予測
- 世界のヒトヘルパーウイルス5（HHV-5）治療薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Roche、Livzon Pharmaceuticals、Sichuan Cologne Pharmaceutical、Hubei Branch benefits medicine、GlaxoSmithKline、Upright and clear、Chongqing Winbond (acquisition of Sichuan Mingxin)、Haikou Kellett、On the drug new Asia、Chongqing Fu'an Pharmaceutical、Shandong Luo Xin Pharmaceutical、Yangtze River Pharmaceutical、Qianjiang Pharmaceuticals、Wuhan Hualong
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ガンシクロビル、バレリアンギリビル製剤、アシクロビル製剤、バラシクロビル製剤、ホスカルネットナトリウム製剤
・用途別分析2017年-2028年：免疫不全群集、臓器移植群群、CMVヘルペス群集
・ヒトヘルパーウイルス5（HHV-5）治療薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ヒトヘルパーウイルス5（HHV-5）治療薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ヒトヘルパーウイルス5（HHV-5）治療薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ヒトヘルパーウイルス5（HHV-5）治療薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ヒトヘルパーウイルス5（HHV-5）治療薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Human Herpersvirus 5 (HHV-5) Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Human Herpersvirus 5 (HHV-5) Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Immunodeficiency Crowd accounting for % of the Human Herpersvirus 5 (HHV-5) Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Ganciclovir segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Human Herpersvirus 5 (HHV-5) Drug include Roche, Livzon Pharmaceuticals, Sichuan Cologne Pharmaceutical, Hubei Branch benefits medicine, and GlaxoSmithKline, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Human Herpersvirus 5 (HHV-5) Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Ganciclovir
Valerian Gilivir Drugs
Acyclovir Drugs
Valacyclovir Drugs
Foscarnet Sodium Drugs
Market segment by Application can be divided into
Immunodeficiency Crowd
Organ Transplant Crowd
CMV Herpes Crowd
The key market players for global Human Herpersvirus 5 (HHV-5) Drug market are listed below:
Roche
Livzon Pharmaceuticals
Sichuan Cologne Pharmaceutical
Hubei Branch benefits medicine
GlaxoSmithKline
Upright and clear
Chongqing Winbond (acquisition of Sichuan Mingxin)
Haikou Kellett
On the drug new Asia
Chongqing Fu’an Pharmaceutical
Shandong Luo Xin Pharmaceutical
Yangtze River Pharmaceutical
Qianjiang Pharmaceuticals
Wuhan Hualong
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Herpersvirus 5 (HHV-5) Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Herpersvirus 5 (HHV-5) Drug, with price, sales, revenue and global market share of Human Herpersvirus 5 (HHV-5) Drug from 2019 to 2022.
Chapter 3, the Human Herpersvirus 5 (HHV-5) Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Herpersvirus 5 (HHV-5) Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Human Herpersvirus 5 (HHV-5) Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Herpersvirus 5 (HHV-5) Drug.
Chapter 13, 14, and 15, to describe Human Herpersvirus 5 (HHV-5) Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Human Herpersvirus 5 (HHV-5) Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Ganciclovir
1.2.3 Valerian Gilivir Drugs
1.2.4 Acyclovir Drugs
1.2.5 Valacyclovir Drugs
1.2.6 Foscarnet Sodium Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Immunodeficiency Crowd
1.3.3 Organ Transplant Crowd
1.3.4 CMV Herpes Crowd
1.4 Global Human Herpersvirus 5 (HHV-5) Drug Market Size & Forecast
1.4.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Human Herpersvirus 5 (HHV-5) Drug Sales in Volume (2017-2028)
1.4.3 Global Human Herpersvirus 5 (HHV-5) Drug Price (2017-2028)
1.5 Global Human Herpersvirus 5 (HHV-5) Drug Production Capacity Analysis
1.5.1 Global Human Herpersvirus 5 (HHV-5) Drug Total Production Capacity (2017-2028)
1.5.2 Global Human Herpersvirus 5 (HHV-5) Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Herpersvirus 5 (HHV-5) Drug Market Drivers
1.6.2 Human Herpersvirus 5 (HHV-5) Drug Market Restraints
1.6.3 Human Herpersvirus 5 (HHV-5) Drug Trends Analysis
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Human Herpersvirus 5 (HHV-5) Drug Product and Services
2.1.4 Roche Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Livzon Pharmaceuticals
2.2.1 Livzon Pharmaceuticals Details
2.2.2 Livzon Pharmaceuticals Major Business
2.2.3 Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Product and Services
2.2.4 Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sichuan Cologne Pharmaceutical
2.3.1 Sichuan Cologne Pharmaceutical Details
2.3.2 Sichuan Cologne Pharmaceutical Major Business
2.3.3 Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product and Services
2.3.4 Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Hubei Branch benefits medicine
2.4.1 Hubei Branch benefits medicine Details
2.4.2 Hubei Branch benefits medicine Major Business
2.4.3 Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Product and Services
2.4.4 Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Product and Services
2.5.4 GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Upright and clear
2.6.1 Upright and clear Details
2.6.2 Upright and clear Major Business
2.6.3 Upright and clear Human Herpersvirus 5 (HHV-5) Drug Product and Services
2.6.4 Upright and clear Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Chongqing Winbond (acquisition of Sichuan Mingxin)
2.7.1 Chongqing Winbond (acquisition of Sichuan Mingxin) Details
2.7.2 Chongqing Winbond (acquisition of Sichuan Mingxin) Major Business
2.7.3 Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Product and Services
2.7.4 Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Haikou Kellett
2.8.1 Haikou Kellett Details
2.8.2 Haikou Kellett Major Business
2.8.3 Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Product and Services
2.8.4 Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 On the drug new Asia
2.9.1 On the drug new Asia Details
2.9.2 On the drug new Asia Major Business
2.9.3 On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Product and Services
2.9.4 On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Chongqing Fu’an Pharmaceutical
2.10.1 Chongqing Fu’an Pharmaceutical Details
2.10.2 Chongqing Fu’an Pharmaceutical Major Business
2.10.3 Chongqing Fu’an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product and Services
2.10.4 Chongqing Fu’an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Shandong Luo Xin Pharmaceutical
2.11.1 Shandong Luo Xin Pharmaceutical Details
2.11.2 Shandong Luo Xin Pharmaceutical Major Business
2.11.3 Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product and Services
2.11.4 Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Yangtze River Pharmaceutical
2.12.1 Yangtze River Pharmaceutical Details
2.12.2 Yangtze River Pharmaceutical Major Business
2.12.3 Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product and Services
2.12.4 Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Qianjiang Pharmaceuticals
2.13.1 Qianjiang Pharmaceuticals Details
2.13.2 Qianjiang Pharmaceuticals Major Business
2.13.3 Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Product and Services
2.13.4 Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Wuhan Hualong
2.14.1 Wuhan Hualong Details
2.14.2 Wuhan Hualong Major Business
2.14.3 Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Product and Services
2.14.4 Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Human Herpersvirus 5 (HHV-5) Drug Breakdown Data by Manufacturer
3.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Human Herpersvirus 5 (HHV-5) Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Human Herpersvirus 5 (HHV-5) Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Human Herpersvirus 5 (HHV-5) Drug Manufacturer Market Share in 2021
3.5 Global Human Herpersvirus 5 (HHV-5) Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Human Herpersvirus 5 (HHV-5) Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Human Herpersvirus 5 (HHV-5) Drug Market Size by Region
4.1.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Region (2017-2028)
4.2 North America Human Herpersvirus 5 (HHV-5) Drug Revenue (2017-2028)
4.3 Europe Human Herpersvirus 5 (HHV-5) Drug Revenue (2017-2028)
4.4 Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Revenue (2017-2028)
4.5 South America Human Herpersvirus 5 (HHV-5) Drug Revenue (2017-2028)
4.6 Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales in Volume by Type (2017-2028)
5.2 Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Type (2017-2028)
5.3 Global Human Herpersvirus 5 (HHV-5) Drug Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales in Volume by Application (2017-2028)
6.2 Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Application (2017-2028)
6.3 Global Human Herpersvirus 5 (HHV-5) Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2017-2028)
7.2 North America Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2017-2028)
7.3 North America Human Herpersvirus 5 (HHV-5) Drug Market Size by Country
7.3.1 North America Human Herpersvirus 5 (HHV-5) Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Human Herpersvirus 5 (HHV-5) Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2017-2028)
8.2 Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2017-2028)
8.3 Europe Human Herpersvirus 5 (HHV-5) Drug Market Size by Country
8.3.1 Europe Human Herpersvirus 5 (HHV-5) Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Human Herpersvirus 5 (HHV-5) Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Market Size by Region
9.3.1 Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2017-2028)
10.2 South America Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2017-2028)
10.3 South America Human Herpersvirus 5 (HHV-5) Drug Market Size by Country
10.3.1 South America Human Herpersvirus 5 (HHV-5) Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Human Herpersvirus 5 (HHV-5) Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Market Size by Country
11.3.1 Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Human Herpersvirus 5 (HHV-5) Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Human Herpersvirus 5 (HHV-5) Drug
12.3 Human Herpersvirus 5 (HHV-5) Drug Production Process
12.4 Human Herpersvirus 5 (HHV-5) Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Human Herpersvirus 5 (HHV-5) Drug Typical Distributors
13.3 Human Herpersvirus 5 (HHV-5) Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Human Herpersvirus 5 (HHV-5) Drug Product and Services
Table 6. Roche Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Livzon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Livzon Pharmaceuticals Major Business
Table 9. Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Product and Services
Table 10. Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sichuan Cologne Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 12. Sichuan Cologne Pharmaceutical Major Business
Table 13. Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product and Services
Table 14. Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Hubei Branch benefits medicine Basic Information, Manufacturing Base and Competitors
Table 16. Hubei Branch benefits medicine Major Business
Table 17. Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Product and Services
Table 18. Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 20. GlaxoSmithKline Major Business
Table 21. GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Product and Services
Table 22. GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Upright and clear Basic Information, Manufacturing Base and Competitors
Table 24. Upright and clear Major Business
Table 25. Upright and clear Human Herpersvirus 5 (HHV-5) Drug Product and Services
Table 26. Upright and clear Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Chongqing Winbond (acquisition of Sichuan Mingxin) Basic Information, Manufacturing Base and Competitors
Table 28. Chongqing Winbond (acquisition of Sichuan Mingxin) Major Business
Table 29. Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Product and Services
Table 30. Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Haikou Kellett Basic Information, Manufacturing Base and Competitors
Table 32. Haikou Kellett Major Business
Table 33. Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Product and Services
Table 34. Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. On the drug new Asia Basic Information, Manufacturing Base and Competitors
Table 36. On the drug new Asia Major Business
Table 37. On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Product and Services
Table 38. On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Chongqing Fu'an Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 40. Chongqing Fu'an Pharmaceutical Major Business
Table 41. Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product and Services
Table 42. Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Shandong Luo Xin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Shandong Luo Xin Pharmaceutical Major Business
Table 45. Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product and Services
Table 46. Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Yangtze River Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 48. Yangtze River Pharmaceutical Major Business
Table 49. Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product and Services
Table 50. Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Qianjiang Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 52. Qianjiang Pharmaceuticals Major Business
Table 53. Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Product and Services
Table 54. Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Wuhan Hualong Basic Information, Manufacturing Base and Competitors
Table 56. Wuhan Hualong Major Business
Table 57. Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Product and Services
Table 58. Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 60. Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 61. Market Position of Manufacturers in Human Herpersvirus 5 (HHV-5) Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 62. Global Human Herpersvirus 5 (HHV-5) Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 63. Head Office and Human Herpersvirus 5 (HHV-5) Drug Production Site of Key Manufacturer
Table 64. Human Herpersvirus 5 (HHV-5) Drug New Entrant and Capacity Expansion Plans
Table 65. Human Herpersvirus 5 (HHV-5) Drug Mergers & Acquisitions in the Past Five Years
Table 66. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Region (2017-2022) & (K Units)
Table 67. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Region (2023-2028) & (K Units)
Table 68. Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Region (2017-2022) & (USD Million)
Table 69. Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Region (2023-2028) & (USD Million)
Table 70. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2017-2022) & (K Units)
Table 71. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2023-2028) & (K Units)
Table 72. Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Type (2017-2022) & (USD Million)
Table 73. Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Type (2023-2028) & (USD Million)
Table 74. Global Human Herpersvirus 5 (HHV-5) Drug Price by Type (2017-2022) & (US$/Unit)
Table 75. Global Human Herpersvirus 5 (HHV-5) Drug Price by Type (2023-2028) & (US$/Unit)
Table 76. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2017-2022) & (K Units)
Table 77. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2023-2028) & (K Units)
Table 78. Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Application (2017-2022) & (USD Million)
Table 79. Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Application (2023-2028) & (USD Million)
Table 80. Global Human Herpersvirus 5 (HHV-5) Drug Price by Application (2017-2022) & (US$/Unit)
Table 81. Global Human Herpersvirus 5 (HHV-5) Drug Price by Application (2023-2028) & (US$/Unit)
Table 82. North America Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2017-2022) & (K Units)
Table 83. North America Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2023-2028) & (K Units)
Table 84. North America Human Herpersvirus 5 (HHV-5) Drug Revenue by Country (2017-2022) & (USD Million)
Table 85. North America Human Herpersvirus 5 (HHV-5) Drug Revenue by Country (2023-2028) & (USD Million)
Table 86. North America Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2017-2022) & (K Units)
Table 87. North America Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2023-2028) & (K Units)
Table 88. North America Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2017-2022) & (K Units)
Table 89. North America Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2023-2028) & (K Units)
Table 90. Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2017-2022) & (K Units)
Table 91. Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2023-2028) & (K Units)
Table 92. Europe Human Herpersvirus 5 (HHV-5) Drug Revenue by Country (2017-2022) & (USD Million)
Table 93. Europe Human Herpersvirus 5 (HHV-5) Drug Revenue by Country (2023-2028) & (USD Million)
Table 94. Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2017-2022) & (K Units)
Table 95. Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2023-2028) & (K Units)
Table 96. Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2017-2022) & (K Units)
Table 97. Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2023-2028) & (K Units)
Table 98. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales by Region (2017-2022) & (K Units)
Table 99. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales by Region (2023-2028) & (K Units)
Table 100. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Revenue by Region (2017-2022) & (USD Million)
Table 101. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Revenue by Region (2023-2028) & (USD Million)
Table 102. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2017-2022) & (K Units)
Table 103. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2023-2028) & (K Units)
Table 104. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2017-2022) & (K Units)
Table 105. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2023-2028) & (K Units)
Table 106. South America Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2017-2022) & (K Units)
Table 107. South America Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2023-2028) & (K Units)
Table 108. South America Human Herpersvirus 5 (HHV-5) Drug Revenue by Country (2017-2022) & (USD Million)
Table 109. South America Human Herpersvirus 5 (HHV-5) Drug Revenue by Country (2023-2028) & (USD Million)
Table 110. South America Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2017-2022) & (K Units)
Table 111. South America Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2023-2028) & (K Units)
Table 112. South America Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2017-2022) & (K Units)
Table 113. South America Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2023-2028) & (K Units)
Table 114. Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Sales by Region (2017-2022) & (K Units)
Table 115. Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Sales by Region (2023-2028) & (K Units)
Table 116. Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Revenue by Region (2017-2022) & (USD Million)
Table 117. Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Revenue by Region (2023-2028) & (USD Million)
Table 118. Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2017-2022) & (K Units)
Table 119. Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2023-2028) & (K Units)
Table 120. Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2017-2022) & (K Units)
Table 121. Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2023-2028) & (K Units)
Table 122. Human Herpersvirus 5 (HHV-5) Drug Raw Material
Table 123. Key Manufacturers of Human Herpersvirus 5 (HHV-5) Drug Raw Materials
Table 124. Direct Channel Pros & Cons
Table 125. Indirect Channel Pros & Cons
Table 126. Human Herpersvirus 5 (HHV-5) Drug Typical Distributors
Table 127. Human Herpersvirus 5 (HHV-5) Drug Typical Customers
List of Figures
Figure 1. Human Herpersvirus 5 (HHV-5) Drug Picture
Figure 2. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Type in 2021
Figure 3. Ganciclovir
Figure 4. Valerian Gilivir Drugs
Figure 5. Acyclovir Drugs
Figure 6. Valacyclovir Drugs
Figure 7. Foscarnet Sodium Drugs
Figure 8. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Application in 2021
Figure 9. Immunodeficiency Crowd
Figure 10. Organ Transplant Crowd
Figure 11. CMV Herpes Crowd
Figure 12. Global Human Herpersvirus 5 (HHV-5) Drug Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global Human Herpersvirus 5 (HHV-5) Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Human Herpersvirus 5 (HHV-5) Drug Sales (2017-2028) & (K Units)
Figure 15. Global Human Herpersvirus 5 (HHV-5) Drug Price (2017-2028) & (US$/Unit)
Figure 16. Global Human Herpersvirus 5 (HHV-5) Drug Production Capacity (2017-2028) & (K Units)
Figure 17. Global Human Herpersvirus 5 (HHV-5) Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Human Herpersvirus 5 (HHV-5) Drug Market Drivers
Figure 19. Human Herpersvirus 5 (HHV-5) Drug Market Restraints
Figure 20. Human Herpersvirus 5 (HHV-5) Drug Market Trends
Figure 21. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Manufacturer in 2021
Figure 22. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Manufacturer in 2021
Figure 23. Human Herpersvirus 5 (HHV-5) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Human Herpersvirus 5 (HHV-5) Drug Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Human Herpersvirus 5 (HHV-5) Drug Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Region (2017-2028)
Figure 27. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Region (2017-2028)
Figure 28. North America Human Herpersvirus 5 (HHV-5) Drug Revenue (2017-2028) & (USD Million)
Figure 29. Europe Human Herpersvirus 5 (HHV-5) Drug Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Revenue (2017-2028) & (USD Million)
Figure 31. South America Human Herpersvirus 5 (HHV-5) Drug Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Revenue (2017-2028) & (USD Million)
Figure 33. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type (2017-2028)
Figure 34. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Type (2017-2028)
Figure 35. Global Human Herpersvirus 5 (HHV-5) Drug Price by Type (2017-2028) & (US$/Unit)
Figure 36. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application (2017-2028)
Figure 37. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Application (2017-2028)
Figure 38. Global Human Herpersvirus 5 (HHV-5) Drug Price by Application (2017-2028) & (US$/Unit)
Figure 39. North America Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type (2017-2028)
Figure 40. North America Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application (2017-2028)
Figure 41. North America Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Country (2017-2028)
Figure 42. North America Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Country (2017-2028)
Figure 43. United States Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type (2017-2028)
Figure 47. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application (2017-2028)
Figure 48. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Country (2017-2028)
Figure 49. Europe Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Country (2017-2028)
Figure 50. Germany Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Region (2017-2028)
Figure 59. China Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type (2017-2028)
Figure 66. South America Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application (2017-2028)
Figure 67. South America Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Country (2017-2028)
Figure 68. South America Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Human Herpersvirus 5 (HHV-5) Drug in 2021
Figure 80. Manufacturing Process Analysis of Human Herpersvirus 5 (HHV-5) Drug
Figure 81. Human Herpersvirus 5 (HHV-5) Drug Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ヒト絨毛性ゴナドトロピン（HCG）のグローバル市場展望 2023年-2029年：u-hCG、r-hCG
  • 世界の組換えヒトインターロイキン2注射市場2022年：市場規模予測（～2028年）
  • 短時間作用型ヒトインターフェロンα1bのグローバル市場展望 2023年-2029年：粉体射出、水系射出
  • 世界のヒスタミン ヒト免疫グロブリン市場2022年：市場規模予測（～2028年）
  • 世界の人間用足真菌市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19393 )"世界のヒトヘルパーウイルス5（HHV-5）治療薬市場2022年：市場規模予測（～2028年）" (英文：Global Human Herpersvirus 5 (HHV-5) Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。